These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10215073)

  • 1. Urinary free beta hCG, beta core fragment and total oestriol as markers of Down syndrome in the second trimester of pregnancy.
    Hsu JJ; Spencer K; Aitken DA; Crossley J; Choi T; Ozaki M; Tazawa H
    Prenat Diagn; 1999 Feb; 19(2):146-58. PubMed ID: 10215073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining beta-core fragment and total oestriol measurements to test for Down syndrome pregnancies.
    Cole LA; Acuna E; Isozaki T; Palomaki GE; Bahado-Singh RO; Mahoney MO
    Prenat Diagn; 1997 Dec; 17(12):1125-33. PubMed ID: 9467809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
    Spencer K; Aitken DA; Macri JN; Buchanan PD
    Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG.
    Cole LA; Shahabi S; Oz UA; Rinne KM; Omrani A; Bahado-Singh RO; Mahoney MJ
    Prenat Diagn; 1999 Apr; 19(4):351-9. PubMed ID: 10327141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
    Talbot JA; Spencer K; Abushoufa RA
    Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hCG and the free beta-subunit as screening tests for Down syndrome.
    Knight GJ; Palomaki GE; Neveux LM; Fodor KK; Haddow JE
    Prenat Diagn; 1998 Mar; 18(3):235-45. PubMed ID: 9556040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.
    Spencer K; Bindra R; Cacho AM; Nicolaides KH
    Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-trimester marker ratios in prenatal screening for Down syndrome.
    Wald NJ; Bestwick JP; Morris JK
    Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second trimester levels of pregnancy associated plasma protein-A in cases of trisomy 18.
    Spencer K; Crossley JA; Green K; Worthington DJ; Brownbill K; Aitken DA
    Prenat Diagn; 1999 Dec; 19(12):1127-34. PubMed ID: 10590430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndrome.
    Kellner LH; Canick JA; Palomaki GE; Neveux LM; Saller DN; Walker RP; Osathanondh R; Bombard AT
    Prenat Diagn; 1997 Dec; 17(12):1135-41. PubMed ID: 9467810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG.
    Spencer K; Noble P; Snijders RJ; Nicolaides KH
    Prenat Diagn; 1997 Jun; 17(6):525-38. PubMed ID: 9203211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-trimester levels of pregnancy-associated plasma protein-A and free beta-hCG in pregnancies with trisomy 13.
    Spencer K; Crossley JA; Aitken DA; Nicolaides KH
    Prenat Diagn; 2005 May; 25(5):358-61. PubMed ID: 15906423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second trimester two-step trisomy 18 screening using maternal serum markers.
    Muller F; Sault C; Lemay C; Roussel-Mizon N; Forestier F; Frendo JL;
    Prenat Diagn; 2002 Jul; 22(7):605-8. PubMed ID: 12124697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary screening tests for fetal Down syndrome: I. Fresh beta-core fragment.
    Cole LA; Rinne KM; Mahajan SM; Oz UA; Shahabi S; Mahoney MJ; Bahado-Singh RO
    Prenat Diagn; 1999 Apr; 19(4):340-50. PubMed ID: 10327140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-trimester dimeric inhibin-A in Down's syndrome screening.
    Spencer K; Wallace EM; Ritoe S
    Prenat Diagn; 1996 Dec; 16(12):1101-10. PubMed ID: 8994245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies.
    Ong CY; Lee CP; Leung KY; Lau E; Tang MH
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):651-5. PubMed ID: 16946227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.